Endo International plc [NASDAQ: ENDP] stock went on a downward path that fall over -2.69% on Thursday, amounting to a one-week price decrease of less than -7.81%. The company report on May 7, 2021 that Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance.
– Endo International plc (NASDAQ: ENDP) reported financial results for the first-quarter ended March 31, 2021.
“I am proud of the continued strong execution across each of Endo’s business segments as reflected by our better than expected first-quarter 2021 results. During the quarter, our Branded Pharmaceuticals segment returned to growth, driven by strong demand for XIAFLEX® and other physician administered products,” said Blaise Coleman, President and Chief Executive Officer at Endo.
Over the last 12 months, ENDP stock rose by 29.59%. The one-year Endo International plc stock forecast points to a potential upside of 29.48. The average equity rating for ENDP stock is currently 2.90, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $1.29 billion, with 230.30 million shares outstanding and 227.03 million shares in the current float. Compared to the average trading volume of 3.41M shares, ENDP stock reached a trading volume of 3846523 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Endo International plc [ENDP]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ENDP shares is $7.70 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ENDP stock is a recommendation set at 2.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for Endo International plc shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on April 07, 2021. While these analysts kept the previous recommendation, Goldman raised their target price to Sell. The new note on the price target was released on July 27, 2020, representing the official price target for Endo International plc stock. Previously, the target price had yet another raise to $7, while Citigroup analysts kept a Buy rating on ENDP stock. On January 03, 2020, analysts increased their price target for ENDP shares from 5 to 7.
The Average True Range (ATR) for Endo International plc is set at 0.36, with the Price to Sales ratio for ENDP stock in the period of the last 12 months amounting to 0.44. Price to Free Cash Flow for ENDP in the course of the last twelve months was 3.93 with Quick ratio for the last quarter at 1.60.
ENDP Stock Performance Analysis:
Endo International plc [ENDP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.81. With this latest performance, ENDP shares dropped by -19.67% in over the last four-week period, additionally plugging by 22.85% over the last 6 months – not to mention a rise of 29.59% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ENDP stock in for the last two-week period is set at 33.09, with the RSI for the last a single of trading hit 30.68, and the three-weeks RSI is set at 35.72 for Endo International plc [ENDP]. The present Moving Average for the last 50 days of trading for this stock 6.99, while it was recorded at 5.62 for the last single week of trading, and 5.69 for the last 200 days.
Insight into Endo International plc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Endo International plc [ENDP] shares currently have an operating margin of +20.78 and a Gross Margin at +50.31. Endo International plc’s Net Margin is presently recorded at +8.52.
Return on Total Capital for ENDP is now 7.85, given the latest momentum, and Return on Invested Capital for the company is 3.24. Additionally, ENDP Total Debt to Total Capital is recorded at 108.36, with Total Debt to Total Assets ending up at 90.62.
Reflecting on the efficiency of the workforce at the company, Endo International plc [ENDP] managed to generate an average of $72,848 per employee. Receivables Turnover for the company is 5.32 with a Total Asset Turnover recorded at a value of 0.31.Endo International plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.60 and a Current Ratio set at 1.90.
ENDP Stock EPS
With the latest financial reports released by the company, Endo International plc posted 0.95/share EPS, while the average EPS was predicted by analysts to be reported at 0.55/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 72.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ENDP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Endo International plc go to -5.30%.
Endo International plc [ENDP] Insider Position Details
There are presently around $1,082 million, or 85.00% of ENDP stock, in the hands of institutional investors. The top three institutional holders of ENDP stocks are: BLACKROCK INC. with ownership of 36,714,699, which is approximately 2.016% of the company’s market cap and around 1.10% of the total institutional ownership; VANGUARD GROUP INC, holding 25,337,239 shares of the stock with an approximate value of $141.38 million in ENDP stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $109.36 million in ENDP stock with ownership of nearly 7.369% of the company’s market capitalization.
Positions in Endo International plc stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 85 institutional holders increased their position in Endo International plc [NASDAQ:ENDP] by around 23,269,843 shares. Additionally, 94 investors decreased positions by around 16,266,274 shares, while 34 investors held positions by with 154,401,129 shares. The mentioned changes placed institutional holdings at 193,937,246 shares, according to the latest SEC report filing. ENDP stock had 30 new institutional investments in for a total of 1,262,813 shares, while 27 institutional investors sold positions of 2,814,304 shares during the same period.